Nu Skin Enterprises Reports Second-Quarter 2019 Results

PROVO, Utah, Aug. 6, 2019 /PRNewswire/ -- Nu Skin Enterprises, Inc. NUS today announced second-quarter 2019 results.  

Executive Summary

Q2 2019 vs. Prior-Year Quarter

Revenue:

$623.5 million; (11%)

  • (4%) fx impact or ($31 M)

Earnings Per Share (EPS):

$0.83; (8%)

Sales Leaders:

61,563; (14%)

Customers:

1,160,420; +1%

Nu Skin Enterprises Logo (PRNewsfoto/Nu Skin Enterprises, Inc.)

"As previously announced, our second-quarter results were negatively impacted by limited sales meetings, media scrutiny and consumer sentiment in Mainland China in connection with the recently completed 100-day review of the nutrition and direct sales industries," said Ritch Wood, chief executive officer. "Outside of Mainland China, most of our other markets performed in-line with expectations. Our customer numbers remained steady as we continued our customer-focused initiatives globally, while sales leaders declined 14 percent, primarily due to Mainland China."

Q2 2019 Year-Over-Year Operating Results

Revenue:

$623.5 million compared to $704.2 million

  • (4%) fx impact or ($31 M)

Gross Margin:

75.3% compared to 76.1%

  • Higher percentage of manufacturing revenue 
  • Nu Skin business was 77.8% compared to 77.9%
  • Impacted by fx, offset by cost savings

Selling Expenses:

39.4% of revenue compared to 38.7%

  • Nu Skin business was 41.5%

G&A Expenses:

24.0% of revenue compared to 25.6%

Operating Margin:

11.9% compared to 11.8%

Other Income / (Expense):

($3.3) million compared to ($11.2) million

Income Tax Rate:

34.6% compared to 28.8%

EPS:

$0.83 compared to $0.90

 

Stockholder Value

Dividend Payments:

$20.6 million

Stock Repurchases:

Nil

 

Q3 and Full-Year 2019 Outlook

Q3 2019 Revenue:

$595 to $615 million; (9%) to (12%)

•  Approximately (2%) fx impact

Q3 2019 EPS:

$0.74 to $0.81

2019 Revenue:

$2.48 billion to $2.52 billion; (6%) to (8%)

•  Approximately (3%) to (4%) fx impact

2019 EPS

$3.20 to $3.35

"We remain committed to our long-term growth strategy focused on attracting and retaining customers, and are confident that, despite recent external factors, we are moving in the right direction," said Wood. "We are encouraged by the resumption of some sales leader meetings in key areas of Mainland China. We remain optimistic about our opportunities with several key initiatives slated for the back half of the year around our Nu Skin LIVE global sales conference. Additionally, we will roll-out our new and improved Galvanic Spa beginning in September, which we believe will help drive global revenue. Finally, we are encouraged with the steady sales growth of our manufacturing platform, which we intend to continue to leverage moving forward."

Mark Lawrence, chief financial officer, added, "Consistent with the guidance provided on July 16, we anticipate annual revenue in the $2.48 to $2.52 billion range, with an approximate 3 to 4 percent unfavorable foreign currency impact, and earnings per share of $3.20 to $3.35. For the third quarter, we project revenue of $595 to $615 million, with an approximate 2 percent negative foreign currency impact, and earnings per share of $0.74 to $0.81."

Conference Call

The Nu Skin management team will host a conference call with the investment community today at 5 p.m. (ET). Those wishing to access the webcast, as well as the financial information presented during the call, can visit the Investor Relations page on the company's website at ir.nuskin.com. A replay of the webcast will be available at the same URL through Aug. 20, 2019.

About Nu Skin Enterprises, Inc.

Founded 35 years ago, Nu Skin Enterprises, Inc. (NSE) empowers innovative companies to change the world with sustainable solutions, opportunities, technologies, and life-improving values. The company currently focuses its efforts around innovative consumer products, product manufacturing and controlled environment agriculture technology. The NSE family of companies includes Nu Skin, which develops and distributes a comprehensive line of premium-quality beauty and wellness solutions through a global network of sales leaders in Asia, the Americas, Europe, Africa and the Pacific; and a collection of sustainable manufacturing and technology innovation companies. Nu Skin Enterprises is traded on the New York Stock Exchange under the symbol "NUS." More information is available at nuskinenterprises.com.

Important Information Regarding Forward-Looking Statements: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent the company's current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws and include, but are not limited to, statements of management's expectations regarding the company's performance, growth, product launches, strategies and initiatives; projections regarding revenue, earnings per share, foreign currency fluctuations and other financial items; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as "believe," "expect," "continue," "anticipate," "optimistic," "project," "estimate," "intend," "plan," "continue," "likely," "will," "would," "could," "may," "might," the negative of these words and other similar words.

The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:

  • adverse publicity related to the company's business, products, industry or any legal actions or complaints by the company's sales force or others;
  • risk that direct selling laws and regulations in any of the company's markets, including the United States and Mainland China, may be modified, interpreted or enforced in a manner that results in negative changes to the company's business model or negatively impacts its revenue, sales force or business, including through the interruption of sales activities, loss of licenses, imposition of fines, or any other adverse actions or events;
  • any failure of current or planned initiatives or products to generate interest among the company's sales force and customers and generate sponsoring and selling activities on a sustained basis;
  • uncertainty regarding the continued impact of the 100-day review and negative media and consumer sentiment in Mainland China on our business operations and results;
  • risk of foreign-currency fluctuations and the currency translation impact on the company's business associated with these fluctuations;
  • uncertainties regarding the future financial performance of the businesses the company has acquired;
  • risks related to accurately predicting, delivering or maintaining sufficient quantities of products to support planned initiatives or launch strategies, and increased risk of inventory write-offs if the company over-forecasts demand for a product or changes its planned initiatives or launch strategies;
  • regulatory risks associated with the company's products, which could require the company to modify its claims or inhibit its ability to import or continue selling a product in a market if the product is determined to be a medical device or if the company is unable to register the product in a timely manner under applicable regulatory requirements;
  • unpredictable economic conditions and events globally, including trade policies and tariffs;
  • uncertainties related to interpretation of, and forthcoming regulations under, the recently enacted U.S. tax reform legislation; the company's future tax-planning initiatives; any prospective or retrospective increases in duties on the company's products imported into the company's markets outside of the United States; and any adverse results of tax audits or unfavorable changes to tax laws in the company's various markets; and
  • continued competitive pressures in the company's markets.

The company's financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission. The forward-looking statements set forth the company's beliefs as of the date that such information was first provided, and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change except as required by law.

Non-GAAP Financial Measures: Constant-currency revenue change is a non-GAAP financial measure that removes the impact of fluctuations in foreign-currency exchange rates, thereby facilitating period-to-period comparisons of the company's performance. It is calculated by translating the current period's revenue at the same average exchange rates in effect during the applicable prior-year period and then comparing this amount to the prior-year period's revenue. The company believes that constant-currency revenue change is useful to investors, lenders and analysts because such information enables them to gauge the impact of foreign-currency fluctuations on the company's revenue from period to period.

The following table sets forth revenue for the three-month periods ended June 30, 2019 and 2018 for each of our reportable segments (U.S. dollars in thousands):



Three Months Ended

June 30,







Constant-

Currency



2019



2018



Change



Change

















Nu Skin























Mainland China

$

185,333



$

245,256





(24%)





(19%)

Americas/Pacific



92,841





103,990





(11%)





(6%)

South Korea



84,732





91,624





(8%)





Southeast Asia



75,395





79,223





(5%)





(3%)

Japan



65,251





64,113





2%





2%

Hong Kong/Taiwan



43,712





52,206





(16%)





(14%)

EMEA



43,400





44,010





(1%)





5%

Other



1,249





1,030





21%





21%

Total Nu Skin



591,913





681,452





(13%)





(9%)

Manufacturing



31,557





22,738





39%





39%

Grow Tech



30













Total

$

623,500



$

704,190





(11%)





(7%)

The following table sets forth revenue for the six-month periods ended June 30, 2019 and 2018 for each of our reportable segments (U.S. dollars in thousands):



Six Months Ended

June 30,







Constant-

Currency



2019



2018



Change



Change

















Nu Skin























Mainland China

$

393,821



$

442,787





(11%)





(5%)

Americas/Pacific



179,297





196,279





(9%)





(2%)

South Korea



168,585





180,554





(7%)





(1%)

Southeast Asia



147,890





150,083





(1%)





1%

Japan



127,360





127,337









1%

Hong Kong/Taiwan



84,270





93,198





(10%)





(7%)

EMEA



85,218





88,991





(4%)





3%

Other



(177)





1,265





(114%)





(114%)

Total Nu Skin



1,186,264





1,280,494





(7%)





(2%)

Manufacturing



60,829





39,915





52%





52%

Grow Tech



30













Total

$

1,247,123



$

1,320,409





(6%)





(1%)

The company's Customers and Sales Leaders statistics by segment for the three-month periods ended June 30 are presented in the following table:



As of

June 30, 2019



As of

June 30, 2018



% Increase (Decrease)



Customers



Sales

Leaders



Customers



Sales

Leaders



Customers



Sales

Leaders

























Mainland China



226,877





24,336





209,456





33,378





8%





(27%)

Americas/Pacific



253,684





8,161





265,431





8,964





(4%)





(9%)

South Korea



180,365





7,239





183,978





6,875





(2%)





5%

Southeast Asia



137,450





7,417





134,601





7,597





2%





(2%)

Japan



127,900





5,931





131,593





5,972





(3%)





(1%)

Hong Kong/Taiwan



70,089





4,223





75,828





4,196





(8%)





1%

EMEA



164,055





4,256





147,048





4,355





12%





(2%)





































Total



1,160,420





61,563





1,147,935





71,337





1%





(14%)

"Customers" are persons who purchased products directly from the company during the previous three months. Our Customer numbers do not include consumers who purchase products directly from members of our sales force.

"Sales Leaders" are independent distributors, and sales employees and independent marketers in China, who achieve certain qualification requirements.

NU SKIN ENTERPRISES, INC.

Consolidated Statements of Income (Unaudited)

(U.S. dollars in thousands, except per share amounts)





Three Months Ended

June 30,



Six Months Ended

June 30,



2019



2018



2019



2018

























Revenue

$

623,500



$

704,190



$

1,247,123



$

1,320,409

Cost of sales



154,028





168,549





300,692





314,830

Gross profit



469,472





535,641





946,431





1,005,579

























Operating expenses:























Selling expenses



245,828





272,757





495,536





530,459

General and administrative expenses



149,442





180,120





308,040





333,366

Total operating expenses



395,270





452,877





803,576





863,825

























Operating income



74,202





82,764





142,855





141,754

Other income (expense), net



(3,326)





(11,165)





(6,174)





(9,958)

























Income before provision for income taxes



70,876





71,599





136,681





131,796

Provision for income taxes



24,527





20,638





47,330





45,296

























Net income

$

46,349



$

50,961



$

89,351



$

86,500

























Net income per share:























Basic

$

0.83



$

0.92



$

1.61



$

1.58

Diluted

$

0.83



$

0.90



$

1.59



$

1.53

























Weighted-average common shares outstanding (000s):























Basic



55,536





55,608





55,486





54,807

Diluted



55,943





56,713





56,030





56,430

 

NU SKIN ENTERPRISES, INC.

Consolidated Balance Sheets (Unaudited)

(U.S. dollars in thousands)





   June 30,

2019



December 31,

2018

ASSETS







Current assets:







Cash and cash equivalents

$

360,632



$

386,911

Current investments



7,733





11,346

Accounts receivable



61,571





53,282

Inventories, net



292,696





295,821

Prepaid expenses and other



65,551





51,877

 Total current assets



788,183





799,237













Property and equipment, net



442,990





464,535

Right-of-use assets



118,507





Goodwill



196,573





196,573

Other intangible assets, net



84,482





89,989

Other assets



160,363





144,112

Total assets

$

1,791,098



$

1,694,446













LIABILITIES AND STOCKHOLDERS' EQUITY











Current liabilities:











Accounts payable

$

48,551



$

47,617

Accrued expenses



306,497





322,583

Current portion of long-term debt



59,500





69,455

 Total current liabilities



414,548





439,655

























Operating lease liabilities



84,102





Long-term debt



348,986





361,008

Other liabilities



108,512





111,916

Total liabilities



956,148





912,579

























Stockholders' equity:











Class A common stock



91





91

Additional paid-in capital



556,294





552,564

Treasury stock, at cost



(1,324,834)





(1,326,605)

Accumulated other comprehensive loss



(81,276)





(79,934)

Retained earnings



1,684,675





1,635,751

Total stockholders' equity



834,950





781,867

Total liabilities and stockholders' equity

$

1,791,098



$

1,694,446

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/nu-skin-enterprises-reports-second-quarter-2019-results-300897555.html

SOURCE Nu Skin Enterprises, Inc.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsPress ReleasesConference Call Announcements
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!